Search

everythinglearnresearchcommunity

for

Search:↓

Platelet Rich Plasma-Derived Extracellular Vesicles show promise for healing and regeneration but need standardized methods for consistent results.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

The endocannabinoid system affects oil production and inflammation in skin cells.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Cannabinoids may help treat various skin conditions.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Tph cells are linked to the severity of systemic lupus erythematosus.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Hydroxychloroquine effectively treated a woman's lupus skin issues and hair loss.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Hair cortisol is a reliable marker of long-term cortisol levels and is linked to daytime saliva cortisol but not morning levels.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

New nanoparticles deliver plant extracts to hair follicles to treat conditions like hair loss and acne.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Minoxidil may help hair growth by stopping immune system attacks on hair follicles.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Confocal Laser Scanning Microscopy (CLSM) is a useful tool for studying how drugs interact with skin and diagnosing skin disorders, despite some limitations.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.